itting in freezer at Boston Children’s Hospital is a drug you won’t find anywhere else. It’s called milasen, and the 18 g that the hospital custom-ordered nearly 2 years ago should last for decades. That’s because milasen was designed to treat a single patient—a now 8-year-old girl named Mila Makovec.
Milasen was built on decades of work on a class of drugs called antisense oligonucleotides. But after Boston Children’s Hospital scientist Timothy Yu diagnosed Mila with a never-before-seen genetic mutation, he took only 10 months to go from idea to injection. It’s a record-shattering sprint in the typical drug-development marathon, and an unprecedented degree of personalization for a chemical drug.
2More
Empowered Patient Podcast: Overcoming Fear of Aging with Heidi Rataj Documentary Produc... - 1 views
1More
Mt. Sinai Merger Shuts New York's Integrative Medicine "Crown Jewel" - 0 views
1More
Meet Master Yuantong Liu - Hunyuan Qi Therapy - 0 views
« First
‹ Previous
641 - 660
Next ›
Last »
Showing 20▼ items per page